← BIOLIFE SOLUTIONS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $8.2m |
$11.0m
+33.97%
|
$19.7m
+79.12%
|
$27.4m
+38.64%
|
$48.1m
+75.69%
|
$119.2m
+147.79%
|
$161.8m
+35.75%
|
$143.3m
-11.43%
|
$82.3m
-42.59%
|
$96.2m
+16.97%
|
$106.7m
+10.89%
|
|
| Cost of Revenue | $3.4m |
$4.3m
+23.98%
|
$6.2m
+45.42%
|
$8.8m
+40.90%
|
$39.1m
+345.83%
|
$82.1m
+110.24%
|
$107.9m
+31.46%
|
$96.5m
-10.58%
|
$28.6m
-70.39%
|
$34.1m
+19.29%
|
$38.8m
+13.86%
|
|
| Gross Profit (derived) | $4.8m |
$6.7m
+41.18%
|
$13.5m
+100.48%
|
$18.6m
+37.60%
|
$9.0m
-51.47%
|
$37.0m
+310.19%
|
$53.8m
+45.28%
|
$41.3m
-23.23%
|
$50.1m
+21.24%
|
$62.1m
+24.00%
|
$67.9m
+9.25%
|
|
| Research and Development Expense | $2.0m | $1.2m | $1.3m | $3.2m | $6.7m | $11.8m | $14.8m | $18.8m | $7.9m | $7.6m | $9.8m | |
| Selling and Marketing Expense | $3.0m | $2.1m | $2.6m | $4.7m | $6.4m | $14.0m | $21.6m | $24.6m | $9.6m | $9.8m | $56.0m | |
| General and Administrative Expense | $4.6m | $4.5m | $6.0m | $8.9m | $14.6m | $32.4m | $47.7m | $55.7m | $40.5m | $45.5m | $45.8m | |
| Amortization of Intangible Assets | — | — | — | $1.1m | $3.0m | $8.2m | $9.7m | $5.2m | $2.7m | $263k | — | |
| Operating Expenses | $9.6m | $7.8m | $9.9m | — | — | — | — | — | — | — | $104.9m | |
| Operating Income (Loss) | ($4.9m) |
($1.1m)
+78.24%
|
$3.7m
+446.83%
|
($220k)
-106.01%
|
($5.6m)
-2434.09%
|
($33.9m)
-508.79%
|
($145.5m)
-328.82%
|
($70.8m)
+51.34%
|
($7.1m)
+89.93%
|
($16.6m)
-132.88%
|
$1.7m
+110.52%
|
|
| Interest Expense | — | $190k | $5k | $5k | — | — | — | — | — | — | $4k | |
| Gain (Loss) on Investments | — | — | — | — | $1.3m | $0 | $697k | $0 | ($4.1m) | $0 | — | |
| Other Nonoperating Income (Expense) | $2k | $350 | $281k | ($13k) | $0 | $289k | $704k | $1.3m | $497k | $1.8m | — | |
| Income (Loss) from Equity Method Investments | — | ($1.0m) | ($672k) | ($739k) | $0 | — | — | — | — | — | — | |
| Other Income | $2k | $350 | $281k | ($13k) | $0 | $289k | $704k | $1.3m | $497k | $1.8m | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | $501k | $58k | ($432k) | ($687k) | ($1.8m) | ($719k) | $2.7m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | $2.5m | $3.3m | $3.2m | $597k | ($27.3m) | ($146.1m) | ($67.3m) | $11.4m | ($12.0m) | $6.8m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | $2.5m | $3.3m | ($3.2m) | ($597k) | ($27.8m) | ($144.8m) | ($66.3m) | ($11.4m) | ($12.1m) | $6.8m | |
| Current Income Tax Expense (Benefit) | — | — | — | — | $33k | $9k | $216k | $231k | — | — | ($42.4m) | |
| Income Tax Expense (Benefit) | $0 | $0 | $3.3m | ($1.5m) | ($3.3m) | ($20.1m) | ($5.0m) | $169k | ($38k) | $49k | ($42.4m) | |
| Net Income (Loss) Attributable to Parent | ($6.9m) |
($2.5m)
+63.42%
|
$3.3m
+229.86%
|
($1.7m)
-150.73%
|
$2.7m
+260.95%
|
($7.6m)
-386.28%
|
($139.8m)
-1731.11%
|
($66.4m)
+52.49%
|
($20.2m)
+69.61%
|
($4.6m)
+77.23%
|
$58.0m
+1361.83%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | ($2.7m) |
$2.9m
+207.31%
|
($1.7m)
-156.61%
|
$2.5m
+247.86%
|
($7.6m)
-411.63%
|
($139.8m)
-1731.11%
|
($66.4m)
+52.49%
|
— | — | $58.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($1.2m) | $0 | — | — | — | — | — | — | — | — | $58.0m | |
| Preferred Stock Dividends, Income Statement Impact | — | $212k | $339k | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | — | ($0.21) | $0.18 | ($0.09) | $0.09 | ($0.20) | ($3.29) | ($1.52) | ($0.44) | ($0.09) | $1.20 | |
| Earnings Per Share, Diluted | ($0.54) | ($0.21) | $0.14 | ($0.09) | ($0.03) | ($0.20) | ($3.29) | ($1.52) | ($0.44) | ($0.10) | $1.18 | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | ($1) | $0 | ($0) | $0 | ($0) | ($3) | ($2) | ($0) | ($0) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | ($1) | $0 | ($1) | ($0) | ($0) | ($3) | ($2) | ($0) | ($0) | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 16.3m | 19.5m | 27.3m | 38.5m | 42.5m | 43.7m | 46.1m | 47.8m | 48.4m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 21.6m | — | — | — | — | 43.7m | 46.1m | 48.6m | 49.5m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | — | — | — | $940k | $668k | $1.6m | $18k | $0 | — | — | — | |
| Costs and Expenses | — | — | — | $27.6m | $53.7m | $153.1m | $307.3m | $214.1m | $89.4m | $78.7m | — | |
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | — | — | — | — | $7.2m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | $2.5m | $3.3m | $3.2m | $597k | $27.8m | $144.8m | $66.3m | ($11.4m) | ($12.1m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | $140.0m | $49.4m | ($8.8m) | $7.5m | — |